Oramed Pharmaceuticals Revenue 2011-2019 | ORMP

Oramed Pharmaceuticals revenue from 2011 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Oramed Pharmaceuticals Annual Revenue
(Millions of US $)
2018 $2
2017 $2
2016 $1
2015 $
2014 $
2013 $
2012 $
2012 $
2011 $
Oramed Pharmaceuticals Quarterly Revenue
(Millions of US $)
Q3 2019 $1
Q2 2019 $1
Q1 2018 $1
Q4 2018 $1
Q3 2018 $1
Q2 2018 $1
Q1 2017 $1
Q4 2017 $1
Q3 2017 $1
Q2 2017 $1
Q1 2016 $1
Q4 2016 $0
Q3 2016 $0
Q2 2016 $0
Q1 2015
Q4 2015
Q3 2015
Q2 2015
Q1 2014
Q4 2014
Q3 2014
Q2 2014
Q1 2013
Q4 2013
Q3 2013
Q2 2013
Q2 2012
Q1 2012
Q4 2012
Q3 2012
Q2 2012
Q1 2011
Q4 2011
Q3 2011
Q2 2011
Q1 2010
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.056B $0.002B
Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $150.052B 28.21
Medtronic (MDT) Ireland $144.563B 20.30
Stryker (SYK) United States $81.936B 28.33
Boston Scientific (BSX) United States $59.271B 28.75
Baxter (BAX) United States $44.577B 27.03
EssilorLuxottica Societe Anonyme (ESLOY) France $31.834B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.216B 18.06
Coloplast (CLPBY) Denmark $27.065B 43.21
Lonza Group Ag (LZAGY) Switzerland $26.916B 0.00
Terumo (TRUMY) Japan $23.348B 26.85
Smith & Nephew SNATS (SNN) United Kingdom $20.643B 0.00
ResMed (RMD) United States $19.620B 37.41
Sunny Optical Technology (SNPTF) China $14.851B 0.00
Bio-Rad Laboratories (BIO) United States $10.257B 54.98
Insulet (PODD) United States $9.281B 549.93
Canopy Growth (CGC) Canada $9.211B 0.00
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $7.050B 21.02
Haemonetics (HAE) United States $6.871B 51.85
Perrigo (PRGO) Ireland $6.520B 12.01
GN STORE NORD (GNNDY) Denmark $6.268B 32.01
Aurora Cannabis (ACB) Canada $5.942B 58.40
GW Pharmaceuticals (GWPH) United Kingdom $4.611B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.773B 62.76
NuVasive (NUVA) United States $3.412B 27.20
ICU Medical (ICUI) United States $3.409B 22.11
Hutchison China MediTech (HCM) China $2.720B 0.00
Agios Pharmaceuticals (AGIO) United States $2.553B 0.00
Quidel (QDEL) United States $2.549B 25.31
National Vision Holdings (EYE) United States $2.221B 47.93
Cardiovascular Systems (CSII) United States $1.770B 0.00
Aphria (APHA) $1.652B 0.00
Phibro Animal Health (PAHC) United States $1.292B 19.36
AtriCure (ATRC) United States $1.054B 0.00
VAREX IMAGING (VREX) United States $1.047B 24.12
Omeros (OMER) United States $1.003B 0.00
NanoString Technologies (NSTG) United States $0.957B 0.00
PetIQ (PETQ) United States $0.902B 21.30
Lantheus Holdings (LNTH) United States $0.900B 23.65
Eagle Pharmaceuticals (EGRX) United States $0.806B 20.56
Cerus (CERS) United States $0.773B 0.00
MacroGenics (MGNX) United States $0.751B 0.00
Quanterix (QTRX) United States $0.687B 0.00
TG Therapeutics (TGTX) United States $0.641B 0.00
LeMaitre Vascular (LMAT) United States $0.629B 37.27
Surmodics (SRDX) United States $0.604B 114.72
OraSure Technologies (OSUR) United States $0.453B 20.97
United Health Products (UEEC) United States $0.433B 0.00
Meridian Bioscience (VIVO) United States $0.419B 13.09
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.399B 0.00
BioLife Solutions (BLFS) United States $0.395B 129.88
Utah Medical Products (UTMD) United States $0.346B 25.35
Zynex (ZYXI) United States $0.336B 35.65
Owens & Minor (OMI) United States $0.296B 8.87
Bovie Medical (APYX) United States $0.265B 0.00
Vapotherm (VAPO) United States $0.229B 0.00
Cytosorbents (CTSO) United States $0.156B 0.00
Rockwell Medical (RMTI) United States $0.154B 0.00
Fonar (FONR) United States $0.154B 8.11
Chimerix (CMRX) United States $0.148B 0.00
Female Health (VERU) United States $0.131B 0.00
InfuSystems Holdings (INFU) United States $0.098B 0.00
United-Guardian (UG) United States $0.090B 21.22
Chembio Diagnostics (CEMI) United States $0.089B 0.00
Surface Oncology (SURF) United States $0.059B 0.00
Nephros (NEPH) United States $0.053B 0.00
MRI INTERVENTNS (MRIC) United States $0.046B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.035B 0.00
Myomo (MYO) United States $0.014B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00